BACKGROUND: Influenza affects host susceptibility to pneumococcus. We sought to evaluate whether this relationship varies by pneumococcal serotype using a large epidemiological database covering 3 decades. METHODS: Weekly rates of invasive pneumococcal pneumonia (IPP) were obtained from the Danish National Laboratory Surveillance System, and influenza-like illness (ILI) data were collected from Danish sentinel surveillance, Statens Serum Institut, 1977-2007. We fit Poisson regression models for each age and comorbidity group, with predictors for seasonality and secular changes, ILI activity, and serotype. RESULTS: Among individuals with low levels of comorbidities, influenza had the largest impact on IPP incidence among low-invasiveness serotypes (influenza attributable percent: 17.9%, 95% confidence interval [CI], 13.6-21.9) as compared with high-invasiveness serotypes (6.7%, 95% CI, 3.8%-11.7%). Among those with higher levels of comorbidities, the effect of influenza was smaller, but high-invasiveness serotypes increased more than low-invasiveness serotypes (8.9% [95% CI, 6.6-11.8] vs. 1.3% [95% CI, -1.6-5.4]. CONCLUSIONS: Influenza was associated with the greatest increases in the incidence of disease caused by serotypes with lower invasive potential and among individuals with low levels of comorbid conditions. The importance of influenza for adult IPP varies by serotype and host comorbidity.
BACKGROUND: Influenza affects host susceptibility to pneumococcus. We sought to evaluate whether this relationship varies by pneumococcal serotype using a large epidemiological database covering 3 decades. METHODS: Weekly rates of invasive pneumococcal pneumonia (IPP) were obtained from the Danish National Laboratory Surveillance System, and influenza-like illness (ILI) data were collected from Danish sentinel surveillance, Statens Serum Institut, 1977-2007. We fit Poisson regression models for each age and comorbidity group, with predictors for seasonality and secular changes, ILI activity, and serotype. RESULTS: Among individuals with low levels of comorbidities, influenza had the largest impact on IPP incidence among low-invasiveness serotypes (influenza attributable percent: 17.9%, 95% confidence interval [CI], 13.6-21.9) as compared with high-invasiveness serotypes (6.7%, 95% CI, 3.8%-11.7%). Among those with higher levels of comorbidities, the effect of influenza was smaller, but high-invasiveness serotypes increased more than low-invasiveness serotypes (8.9% [95% CI, 6.6-11.8] vs. 1.3% [95% CI, -1.6-5.4]. CONCLUSIONS: Influenza was associated with the greatest increases in the incidence of disease caused by serotypes with lower invasive potential and among individuals with low levels of comorbid conditions. The importance of influenza for adult IPP varies by serotype and host comorbidity.
Authors: Zong-Mei Sheng; Daniel S Chertow; Xavier Ambroggio; Sherman McCall; Ronald M Przygodzki; Robert E Cunningham; Olga A Maximova; John C Kash; David M Morens; Jeffery K Taubenberger Journal: Proc Natl Acad Sci U S A Date: 2011-09-19 Impact factor: 11.205
Authors: K Sjöström; C Spindler; A Ortqvist; M Kalin; A Sandgren; S Kühlmann-Berenzon; B Henriques-Normark Journal: Clin Infect Dis Date: 2006-01-17 Impact factor: 9.079
Authors: Nicholas D Walter; Thomas H Taylor; David K Shay; William W Thompson; Lynnette Brammer; Scott F Dowell; Matthew R Moore Journal: Clin Infect Dis Date: 2010-01-15 Impact factor: 9.079
Authors: Justin R Ortiz; Hong Zhou; David K Shay; Kathleen M Neuzil; Ashley L Fowlkes; Christopher H Goss Journal: PLoS One Date: 2011-04-27 Impact factor: 3.240
Authors: Daniel M Weinberger; Krzysztof Trzciński; Ying-Jie Lu; Debby Bogaert; Aaron Brandes; James Galagan; Porter W Anderson; Richard Malley; Marc Lipsitch Journal: PLoS Pathog Date: 2009-06-12 Impact factor: 6.823
Authors: Victoria Magomani; Nicole Wolter; Stefano Tempia; Mignon du Plessis; Linda de Gouveia; Anne von Gottberg Journal: J Clin Microbiol Date: 2014-06-23 Impact factor: 5.948
Authors: Alexis Rybak; Corinne Levy; François Angoulvant; Anne Auvrignon; Piotr Gembara; Kostas Danis; Sophie Vaux; Daniel Levy-Bruhl; Sylvie van der Werf; Stéphane Béchet; Stéphane Bonacorsi; Zein Assad; Andréa Lazzati; Morgane Michel; Florentia Kaguelidou; Albert Faye; Robert Cohen; Emmanuelle Varon; Naïm Ouldali Journal: JAMA Netw Open Date: 2022-06-01
Authors: Ana Paula de O Menezes; Jailton Azevedo; Mariela C Leite; Leila C Campos; Marcelo Cunha; Maria da Gloria S Carvalho; Mitermayer G Reis; Albert I Ko; Daniel M Weinberger; Guilherme Ribeiro; Joice N Reis Journal: Vaccine Date: 2015-12-29 Impact factor: 3.641
Authors: M L Jackson; D Peterson; J C Nelson; S K Greene; S J Jacobsen; E A Belongia; R Baxter; L A Jackson Journal: Epidemiol Infect Date: 2014-12-12 Impact factor: 4.434
Authors: Wilke Hendriks; Hendriek Boshuizen; Arnold Dekkers; Mirjam Knol; Ge A Donker; Arie van der Ende; Hester Korthals Altes Journal: Influenza Other Respir Viruses Date: 2017-01-03 Impact factor: 4.380